Harmonising MEIS Schedule in the Appendix 38 (Table-2) with ITC (HS), 2017

09-09-2017 CA Nagendra Hegde

The Directorate General of Foreign Trade had notified the Harmonised MEIS Schedule in Appendix  3B vide Public Notice NO.61 dated on 07.03.2017. Some of the ITC (HS) 2012 Codes eligible under MEIS were not notified.  

In exercise of powers conferred under Foreign Trade Policy (2015-2020), the Director General of Foreign Trade has notified the MEIS Schedule, Appendix 3B (Table-2) for the ITC(HS) Codes vide Public Notice 17/2015-2020, Dated the 22nd August, 2017 that were not included in the Harmonised list vide Public Notice No.61/201S-20 on 07.03.2017.  

The Harmonised MEIS list as per this Public Notice shows the existing 2012 HS Codes, their description with corresponding 2017 HS Codes and description of goods/products and rates of MEIS applicable.   

The same is available in: http://dgft.gov.in/Exim/2000/PN/PN17/Public notice 17?HYPERLINK "http://dgft.gov.in/Exim/2000/PN/PN17/Public notice 17-eng.pdf"eng.pdf.  

Amendments to Hand Book of Procedures 2015-20: Public Notice 18/2015-2020 dated  

23August, 2017 -  

  1. Para 2.84 of Chapter 2 of I-IBP 2015-2020:  

Status holders shall be entitled to export freely exportable items on free of cost basis for export promotion subject to an annual limit of Rs. 10 lakh or 2% of average annual export realisation during preceding three licensing years, whichever is lower  

  1. Para 2.84 of Chapter-2 of HBP 2015-2020:  

Status holders shall be entitled to export freely exportable items (excluding Gems and Jewellery, Articles of Gold and precious metals) on free of cost basis for export promotion subject to an annual limit of Rupees One Crore or 2% of average annual export realization during preceding three licensing years, whichever is lower. For export of pharma products by pharmaceutical companies, the annual limit would be 2% of the average annual export realisation during preceding three licensing years. In ease of supplies of pharmaceutical products, vaccines and lifesaving drugs to health programmes of international agencies such as UN, WHO-PAHO and Government health programmes, the annual limit shall be up to 8% of the average annual export realisation during preceding three licensing years. Such free of cost supplies shall not be entitled to Duty Drawback or any other export incentive under any export promotion scheme.    

 

The content of the article is property of Hiregange& Associates, Chartered Accountants. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form, or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission, in writing, from the partners of the Firm)